These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 31333661)

  • 21. Targeting vaccines to dendritic cells.
    Foged C; Sundblad A; Hovgaard L
    Pharm Res; 2002 Mar; 19(3):229-38. PubMed ID: 11934227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TLR8 combined withTLR3 or TLR4 agonists enhances DC-NK driven effector Tc1 cells.
    Nouri-Shirazi M; Tamjidi S; Nourishirazi E; Guinet E
    Immunol Lett; 2018 Jan; 193():58-66. PubMed ID: 29103998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Boosting antibody responses by targeting antigens to dendritic cells.
    Caminschi I; Shortman K
    Trends Immunol; 2012 Feb; 33(2):71-7. PubMed ID: 22153931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dendritic cells: translating innate to adaptive immunity.
    Steinman RM; Hemmi H
    Curr Top Microbiol Immunol; 2006; 311():17-58. PubMed ID: 17048704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dendritic cell subtypes as primary targets of vaccines: the emerging role and cross-talk of pattern recognition receptors.
    Benko S; Magyarics Z; Szabó A; Rajnavölgyi E
    Biol Chem; 2008 May; 389(5):469-85. PubMed ID: 18953714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Engineering immunity: Modulating dendritic cell subsets and lymph node response to direct immune-polarization and vaccine efficacy.
    Leleux J; Atalis A; Roy K
    J Control Release; 2015 Dec; 219():610-621. PubMed ID: 26489733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polycation-decorated PLA microspheres induce robust immune responses via commonly used parenteral administration routes.
    Chen X; Wang L; Liu Q; Jia J; Liu Y; Zhang W; Ma G; Su Z
    Int Immunopharmacol; 2014 Dec; 23(2):592-602. PubMed ID: 25466267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting dendritic cells to enhance DNA vaccine potency.
    You Z; Huang X; Hester J; Toh HC; Chen SY
    Cancer Res; 2001 May; 61(9):3704-11. PubMed ID: 11325842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outer membrane vesicles engineered to express membrane-bound antigen program dendritic cells for cross-presentation to CD8
    Schetters STT; Jong WSP; Horrevorts SK; Kruijssen LJW; Engels S; Stolk D; Daleke-Schermerhorn MH; Garcia-Vallejo J; Houben D; Unger WWJ; den Haan JMM; Luirink J; van Kooyk Y
    Acta Biomater; 2019 Jun; 91():248-257. PubMed ID: 31003032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of B cells by a dendritic cell-targeted oral vaccine.
    Sahay B; Owen JL; Yang T; Zadeh M; Lightfoot YL; Ge JW; Mohamadzadeh M
    Curr Pharm Biotechnol; 2013; 14(10):867-77. PubMed ID: 24372255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanogel vaccines targeting dendritic cells: contributions of the surface decoration and vaccine cargo on cell targeting and activation.
    Thomann-Harwood LJ; Kaeuper P; Rossi N; Milona P; Herrmann B; McCullough KC
    J Control Release; 2013 Mar; 166(2):95-105. PubMed ID: 23220107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
    da Cunha A; Antoniazi Michelin M; Cândido Murta EF
    Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD40-expressing plasmid induces anti-CD40 antibody and enhances immune responses to DNA vaccination.
    Xu H; Zhao G; Huang X; Ding Z; Wang J; Wang X; Cheng Y; Kang Y; Wang B
    J Gene Med; 2010 Jan; 12(1):97-106. PubMed ID: 19950201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dendritic cells and humoral immunity in humans.
    Ueno H; Schmitt N; Palucka AK; Banchereau J
    Immunol Cell Biol; 2010; 88(4):376-80. PubMed ID: 20309010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. E2 multimeric scaffold for vaccine formulation: immune response by intranasal delivery and transcriptome profile of E2-pulsed dendritic cells.
    Trovato M; Maurano F; D'Apice L; Costa V; Sartorius R; Cuccaro F; McBurney SP; Krebs SJ; Prisco A; Ciccodicola A; Rossi M; Haigwood NL; De Berardinis P
    BMC Microbiol; 2016 Jul; 16(1):152. PubMed ID: 27421762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccine Designs Utilizing Invariant NKT-Licensed Antigen-Presenting Cells Provide NKT or T Cell Help for B Cell Responses.
    Fujii SI; Yamasaki S; Sato Y; Shimizu K
    Front Immunol; 2018; 9():1267. PubMed ID: 29915600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of Interleukin-10 Producing Dendritic Cells As a Tool to Suppress Allergen-Specific T Helper 2 Responses.
    Schülke S
    Front Immunol; 2018; 9():455. PubMed ID: 29616018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current knowledge about interactions between avian dendritic cells and poultry pathogens.
    Zmrhal V; Slama P
    Dev Comp Immunol; 2020 Mar; 104():103565. PubMed ID: 31830703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cationic micelle based vaccine induced potent humoral immune response through enhancing antigen uptake and formation of germinal center.
    Luo Z; Shi S; Jin L; Xu L; Yu J; Chen H; Li X
    Colloids Surf B Biointerfaces; 2015 Nov; 135():556-564. PubMed ID: 26311662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of anthrax and plague biowarfare vaccine interactions with human monocyte-derived dendritic cells.
    Skowera A; de Jong EC; Schuitemaker JH; Allen JS; Wessely SC; Griffiths G; Kapsenberg M; Peakman M
    J Immunol; 2005 Dec; 175(11):7235-43. PubMed ID: 16301628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.